Cobalt, chromium, and nickel are
used in orthopedic prostheses.
They can be released, accumulate in many organs, and be toxic. The
aim of this study is to evaluate the cytotoxicity of these metals
on human hepatocytes and to improve our knowledge of their cellular
toxicity mechanisms by metabolomic analysis. HepaRG cells were incubated
for 48 h with increasing concentrations of metals to determine their
IC50. Then, a nontargeted metabolomic study using liquid
chromatography–high-resolution mass spectrometry (LC–HRMS)
was done at IC50 and at a lower concentration (100 nM),
near to those found in the blood and liver of patients with prostheses.
IC50 were defined at 940, 2, and 1380 μM for Co,
Cr, and Ni, respectively. In vitro, Cr appears to
be much more toxic than Co and Ni. Metabolomic analysis revealed the
disruption of metabolic pathways from the low concentration of 100
nM, in particular tryptophan metabolism and lipid metabolism illustrated
by an increase in phenylacetylglycine, a marker of phospholipidosis,
for all three metals. They also appear to be responsible for oxidative
stress. Dysregulation of these pathways impacts hepatocyte metabolism
and may result in hepatotoxicity. Further investigations on accessible
biological matrices should be conducted to correlate our in
vitro results with the clinical data of prostheses-bearing
patients.